Home / Pharmaceutical company intelligence
Nabiqasim Industries (Pvt) Ltd., logo
Pharmaceutical company intelligence

Nabiqasim Industries products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Karachi · Pakistan

Pakistan-based pharmaceutical manufacturer producing branded generic formulations with domestic and international operations.

Nabiqasim Industries products in Pakistan

Nabiqasim Industries (Pvt) Ltd has 361 medicine presentations registered in Pakistan under 131 brands, covering 117 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Cardiovascular. Its brands with the most registered strengths and packs are Glempa-M (Empagliflozin + Metformin), Am-Descol (Amlodipine + Atorvastatin), Nixvom (Ondansetron) and Xariva (Rivaroxaban). 361 products have an official DRAP price on MedInfoBase. See all 131 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗ LinkedIn ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation12 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date4 Aug 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Nabiqasim Industries (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
5th Floor, Commerce Centre, Hasrat Mohani Road, Karachi, Pakistan
Phone
+92 21 111 742 762
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000105 Nabi Qasim Industries (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000105 362 linked products · source seen 12 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx432public portfolio records represented
REG343unique registrations represented
IDX0indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER213registry-verified exact registrations
PKR361current validated price records
G117generic molecules in indexed catalogue
DF15dosage-form groups
TA16therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage84%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage87%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixNabiqasim Industries (Pvt) Ltd.,Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nabiqasim-industries-pvt-ltdGenerated 12 Nov 2026Anti-infectives133 · 37%CNS & mental health54 · 15%Cardiovascular51 · 14%Endocrine & metabolic39 · 11%Hematology & thrombosis20 · 6%Gastrointestinal & hepatology20 · 6%Respiratory & allergy10 · 3%Other therapeutic areas34 · 9%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioNabiqasim Industries (Pvt) Ltd.,Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nabiqasim-industries-pvt-ltdGenerated 12 Nov 2026361presentationsTablet222 · 61%Injection38 · 11%Capsule29 · 8%Suspension19 · 5%Cream17 · 5%Sachet9 · 2%Other forms27 · 7%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionNabiqasim Industries (Pvt) Ltd.,Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nabiqasim-industries-pvt-ltdGenerated 12 Nov 2026313comparable productsBelow peer median62 · 20%Near peer median89 · 28%Above peer median162 · 52%Company median price position+5.2%Lowest-price equivalents24Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsNabiqasim Industries (Pvt) Ltd.,Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nabiqasim-industries-pvt-ltdGenerated 12 Nov 2026Bio-Labs(Pvt) Ltd54 shared46% overlapM/s. Genix Pharma (Pvt) Ltd.49 shared42% overlapAtco Laboratories Limited49 shared42% overlapCCL Pharmaceuticals (Pvt.) Limited49 shared42% overlapMacter International Limited48 shared41% overlapMediate Pharmaceutical Pvt Ltd47 shared40% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet222 products
Injection38 products
Capsule29 products
Suspension19 products
Cream17 products
Sachet9 products
Syrup8 products
Gel5 products
Ointment4 products
Solution3 products
Infusion2 products
Pessary2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Nabiqasim Industries (Pvt) Ltd., is priced against the market

313 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers272Distinct registrations among indexed, published, presentation-validated products only
Verified price observations364
Products with a verified price361
Products with multiple price observations3
Source records with multiple versions361
Latest portfolio source check12 Oct 2026
Latest effective price date4 Aug 2026
Latest source observation12 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

343 unique registration(s) · 0 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
No matching products.
A to Z

All 131 Nabiqasim Industries brands in Pakistan

  • Am-Descol Amlodipine + Atorvastatin · 10 mg + 10 mg tablet, 10 mg + 20 mg tablet, 10 mg + 40 mg tablet
  • Amdipine Amlodipine · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
  • Ampril Amlodipine + Lisinopril · 5 mg + 10 mg tablet
  • Asap Acetylsalicylic acid (Aspirin) · 150 mg tablet, 300 mg tablet, 75 mg tablet
  • Asco-C Ascorbic acid · 100 mg tablet, 500 mg tablet
  • Avirlo Lopinavir + Ritonavir · 100 mg + 25 mg tablet, 200 mg + 50 mg tablet
  • Bacip Ciprofloxacin · 250 mg tablet, 250 mg/5 mL suspension, 500 mg tablet
  • Baxim Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • Bepsar Losartan, Losartan + Hydrochlorothiazide · 25 mg tablet, 50 mg tablet, 50 mg + 12.5 mg tablet
  • Bioplex Thiamine + Pyridoxine + Riboflavin + Nicotinamide · 3 mg + 2 mg + 2 mg + 20 mg tablet
  • Buzon Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
  • Calcovorin Calcium folinate (folinic acid) · 50 mg injection
  • Carpro Carvedilol · 12.5 mg tablet, 25 mg tablet, 3.125 mg tablet
  • Cefexol Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 400 mg capsule
  • Cefexol DS Cefixime · 200 mg/5 mL suspension
  • Clarithro Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
  • Clomitab Clomifene citrate · 50 mg tablet
  • Cloxipa Apixaban · 2.5 mg tablet, 5 mg tablet
  • Co-Depricap Olanzapine + Fluoxetine · 12 mg + 25 mg capsule, 3 mg + 25 mg capsule, 6 mg + 25 mg capsule
  • Cortec Enalapril · 10 mg tablet, 5 mg tablet
  • Cortec Plus Enalapril + Hydrochlorothiazide · 10 mg + 25 mg tablet
  • Dapxi Dapagliflozin · 10 mg tablet, 5 mg tablet
  • Dapxi Met Dapagliflozin + Metformin · 5 mg + 1000 mg tablet, 5 mg + 850 mg tablet
  • Dapxi-Met XR Dapagliflozin + Metformin · 5 mg + 500 mg tablet
  • Deplat Clopidogrel · 75 mg tablet
  • Deplat-AP Clopidogrel + Aspirin · 75 mg + 150 mg tablet, 75 mg + 75 mg tablet
  • Depricap Fluoxetine · 20 mg capsule
  • Dermosporin Clotrimazole · 1 % solution
  • Dermosporin-B Betamethasone + Clotrimazole · 10 mg/g + 0.5 mg/g cream
  • Dermosporin-HC Clotrimazole + Hydrocortisone · 1% + 1% cream
  • Dervit Calcipotriol · 50 mcg/g ointment
  • Dervit B Calcipotriol + Betamethasone · 50 mcg/g + 0.5 mg/g ointment
  • Descol Atorvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
  • DIAMET Metformin · 250 mg tablet, 500 mg tablet
  • Diasol Oral rehydration salts (ORS) · NaCl 3.5 g + KCl 1.5 g + NaHCO3 2.5 g + glucose 20 g/sachet sachet
  • Diazepam Diazepam · 5 mg tablet
  • Diuret Hydrochlorothiazide · 25 mg tablet, 50 mg tablet
  • Erabact Ciprofloxacin · 200 mg/100 mL infusion
  • Es-Pramcit Escitalopram · 10 mg tablet, 20 mg tablet, 5 mg tablet
  • Estrolet Letrozole · 2.5 mg tablet
  • Falciject Artesunate · 120 mg injection, 30 mg injection, 60 mg injection
  • Fanart Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet, 80 mg + 480 mg tablet
  • Fenix Fexofenadine · 120 mg tablet, 180 mg tablet, 60 mg tablet
  • Fersul Ferrous sulfate · 200 mg tablet
  • Fluderm Fluconazole · 150 mg capsule, 200 mg capsule, 50 mg capsule
  • Folitab Folic acid · 5 mg tablet
  • Fovirox Tenofovir disoproxil · 300 mg tablet
  • Gesicaine Jelly Lidocaine · 2% gel
  • Glempa Empagliflozin · 10 mg tablet, 25 mg tablet
  • Glempa-M Empagliflozin + Metformin · 12.5 mg + 1000 mg tablet, 12.5 mg + 500 mg tablet, 12.5 mg + 850 mg tablet
  • Glempa-MXR Empagliflozin + Metformin · 12.5 mg + 1000 mg tablet, 5 mg + 1000 mg tablet
  • Glicotron Gliclazide · 30 mg tablet, 60 mg tablet, 80 mg tablet
  • GoodLife EnergyVit Ferrous sulfate + Folic acid · 150 mg + 0.5 mg tablet
  • Gynosporin Clotrimazole · 100 mg pessary, 100 mg/g cream, 2% cream
  • Hoxy-Q Hydroxychloroquine · 200 mg tablet
  • Hypovir Aciclovir · 200 mg tablet, 200 MG/5 mL suspension, 250 mg injection
  • Inzivir Oseltamivir · 75 mg capsule
  • Ioptas Potassium iodide · 130 mg tablet, 65 mg tablet
  • Keptiron Levetiracetam · 100 mg/mL injection, 250 mg tablet, 500 mg tablet
  • Keptiron Tabs Levetiracetam · 250 mg tablet, 500 mg tablet, 750 mg tablet
  • Kleenlac Lactulose · 3.35 g/5 mL syrup
  • Lamozid Lamivudine + Zidovudine · 150 mg + 300 mg tablet
  • Lamvira Lamivudine · 150 mg tablet, 300 mg tablet
  • Linox Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
  • Livent Entecavir · 0.5 mg tablet, 1 mg tablet
  • Lo-Lipid Lovastatin · 20 mg tablet
  • Loprot Omeprazole, Omeprazole + Sodium bicarbonate · 10 mg capsule, 20 mg capsule, 20 mg + 1680 mg sachet
  • Loprot Insta Omeprazole + Sodium bicarbonate · 20 mg + 1680 mg sachet, 40 mg + 1680 mg sachet
  • Lumfort Loratadine · 10 mg tablet, 5 mg syrup, 5 mg/5 mL syrup
  • Maxithro Erythromycin · 200 mg/5 mL suspension
  • Meflox Moxifloxacin · 400 mg tablet
  • Miniquine Chloroquine · 250 mg tablet, 81 mg/5 mL syrup
  • Mycoderm Terbinafine · 1 % cream, 1 % solution, 1% cream
  • Mycoderm Topical Terbinafine · 1 % spray
  • Myzocort Miconazole + Hydrocortisone · 20 mg/g + 10 mg/g cream
  • Myzoderm Miconazole · 20 mg cream
  • Myzogel Miconazole · 20 mg gel
  • Myzovag Vaginal Miconazole · 20 mg cream, 20 mg/g cream
  • Navospet Chlorhexidine gluconate · 7.1 % gel
  • Neset Cetirizine · 10 mg tablet, 5 mg/5 mL syrup
  • Nixmetic Mebendazole · 500 mg tablet
  • Nixvom Ondansetron · 4 mg tablet, 4 mg/2 mL injection, 8 mg tablet
  • Nogotex Colistimethate sodium · 1 MIU injection, 2 MIU injection, 3 MIU injection
  • Normalith SR ' Lithium carbonate · 400 mg tablet
  • Normisar Telmisartan, Telmisartan + Hydrochlorothiazide · 20 mg tablet, 40 mg tablet, 40 mg + 12.5 mg tablet
  • Normisar-AM Telmisartan + Amlodipine · 40 mg + 10 mg tablet, 80 mg + 5 mg tablet
  • Normitab Plus Atenolol + Chlorthalidone · 50 mg + 12.5 mg tablet
  • Normitab-100 Atenolol · 100 mg tablet
  • Normitab-25 Atenolol · 25 mg tablet
  • Normitab-50 Atenolol · 50 mg tablet
  • Normolyte Low Osmolarity Lemon Sodium chloride + Sodium citrate + Potassium chloride + Glucose · 2.6 g + 2.9 g + 1.5 g + 13.5 g sachet
  • Normolyte Low Osmolarity Orange Sodium chloride + Sodium citrate + Potassium chloride + Glucose · 2.6 g + 2.9 g + 1.5 g + 13.5 g sachet
  • Norsal Sodium chloride · 0.9% infusion
  • Nubaquel Quetiapine · 100 mg tablet, 200 mg tablet, 25 mg tablet
  • Nubaquel XR Quetiapine · 150 mg tablet, 200 mg tablet
  • Onzip Olanzapine · 10 mg tablet, 5 mg tablet, 7.5 mg tablet
  • Ophthaflox Ciprofloxacin · 0.3 % drops
  • Penrrem Meropenem · 1 g injection
  • Penrrem, Dry Meropenem · 500 mg injection
  • Pepticure Ranitidine · 150 mg tablet
  • Piquin Dihydroartemisinin + Piperaquine · 40 mg + 320 mg capsule
  • Pramcit Citalopram · 20 mg tablet
  • Predsol Oph. Susp Prednisolone · 10 mg/mL suspension
  • Pronitron Paroxetine · 12.5 mg tablet, 20 mg tablet, 25 mg tablet
  • Proxifer Deferiprone · 500 mg tablet
  • Racona Itraconazole · 100 mg capsule
  • Reliefal Paracetamol · 120 mg/5 mL suspension, 125 mg tablet, 250 mg tablet
  • Reline Sertraline · 100 mg tablet, 50 mg tablet
  • Rivab Ribavirin · 200 mg capsule, 400 mg tablet
  • Romycin Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 250 mg tablet
  • Scabex Permethrin · 5% cream, 50 mg/mL (5%) lotion
  • Silderm Silver sulfadiazine · 1% w/w cream, 10 mg/g cream
  • Simva Simvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
  • Solbovir Sofosbuvir · 400 mg tablet
  • Tazicillin Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
  • Tecmiso Misoprostol · 100 mcg tablet, 200 mcg tablet
  • Tranmax Tranexamic acid · 250 mg/5 mL injection, 500 mg/5 mL injection
  • Triject Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Uriside Furosemide · 20 mg tablet, 40 mg tablet
  • Valset Valproic acid · 250 mg/5 mL syrup
  • Valset Tabs Valproic acid · 250 mg tablet, 500 mg tablet
  • Vanbact Vancomycin · 1 g injection, 500 mg injection
  • Vaspro Hydralazine · 25 mg tablet
  • Vecot Voriconazole · 200 mg injection, 200 mg tablet, 200 mg/5 mL suspension
  • Warior Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
  • Xariva Rivaroxaban · 10 mg tablet, 15 mg tablet, 2.5 mg tablet
  • Zedan Aripiprazole · 10 mg tablet, 15 mg tablet
  • Zidovir Zidovudine · 100 mg capsule, 250 mg capsule
  • Zoldronic Zoledronic acid · 4 mg injection
  • Zuclodep Zuclopenthixol decanoate · 200 mg/mL injection
  • Zynq Zinc sulfate · 20 mg tablet
Questions

Nabiqasim Industries: common questions

How many products does Nabiqasim Industries have in Pakistan?

Nabiqasim Industries (Pvt) Ltd has 361 registered medicine presentations in Pakistan, sold under 131 brands and covering 117 generic medicines.

What are the main brands of Nabiqasim Industries?

By number of registered strengths and packs, its largest brands are Glempa-M (Empagliflozin + Metformin), Am-Descol (Amlodipine + Atorvastatin), Nixvom (Ondansetron), Xariva (Rivaroxaban) and Clarithro (Clarithromycin). This is not a sales ranking.

Which therapy areas does Nabiqasim Industries cover?

The most products are in Anti-infectives (133), CNS & mental health (54), Cardiovascular (51), Endocrine & metabolic (39) and Hematology & thrombosis (20).

Where can I see Nabiqasim Industries medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Nabiqasim Industries (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 12, 2026, from https://medinfobase.com/company/nabiqasim-industries-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9